Rat NPFF1 receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide

Peptides

Volumn 27, Issue 5, 2006, Pages 1005-1014

  Chen, Jin Chung ^a   Lee, Wei Hsin ^a   Chen, Pei Chun ^a   Tseng, Ching Ping ^a   Huang, Eagle Yi Kung ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

cAMP; DARPP 32; FMRFamide; Neuropeptide FF; NPFF1 receptor; PFR(Tic)amide

Indexed keywords

ADENYLATE CYCLASE; AMPHETAMINE; CELL CYCLE PROTEIN; CYCLIC AMP; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPEPTIDE FF; NEUROPEPTIDE FF1 RECEPTOR; NEUROPEPTIDE FF1 RECEPTOR AGONIST; NEUROPEPTIDE RECEPTOR; PEPTIDE; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN DARPP 32; PROLYLPHENYLALANYLARGININE(1,2,3,4 TETRAHYDROISOQUINOLINE 3 CARBOXYLIC ACID)AMIDE; PROTEIN KINASE B; THREONINE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL CLONE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MALE; NEUROPHARMACOLOGY; NONHUMAN; PHARMACODYNAMICS; PHARMACOLOGICAL BLOCKING; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT; RECEPTOR INTRINSIC ACTIVITY; SENSITIZATION; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; AMPHETAMINE; ANALGESIA; ANIMALS; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; FMRFAMIDE; FORSKOLIN; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOTOR ACTIVITY; NEUROPEPTIDES; OLIGOPEPTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PC12 CELLS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE; SIGNAL TRANSDUCTION; TETRAHYDROISOQUINOLINES;

MAMMALIA;

EID: 33646470290     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.09.018     Document Type: Article

References (31)

1. Askwith C.C., Cheng C., Ikuma M., Benson C., Price M.P., and Welsh M.J. Neuropeptide FF and FMRFamide potentiate acid-evoked currents from sensory neurons and proton-gated DEG/ENaC channels. Neuron 26 (2000) 133-141
2. Atherton E., and Sheppard R.C. Solid phase peptide synthesis, a practical approach (1989), IRL Press at Oxford University Press, Oxford, UK
3. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275 (2000) 39324-39331
4. Catarsi S., Babinski K., and Seguela P. Selective modulation of heteromeric ASIC proton-gated channels by neuropeptide FF. Neuropharmacology 41 (2001) 592-600
5. Chen J.C., Li J.Y., Liang K.W., and Huang Y.K. Neuropeptide FF potentiates the behavioral sensitization to amphetamine and alters the levels of neurotransmitters in the medial prefrontal cortex. Brain Res 816 (1999) 220-224
6. Chow L.H., Huang E.Y., Ho S.T., Tsai S.K., and Tao P.L. Dextromethorphan potentiates morphine-induced antinociception at both spinal and supraspinal sites but is not related to the descending serotoninergic or adrenergic pathways. J Biomed Sci 11 (2004) 717-725
7. Deval E., Baron A., Lingueglia E., Mazarguil H., Zajac J.M., and Lazdunski M. Effects of neuropeptide SF and related peptides on acid sensing ion channel 3 and sensory neuron excitability. Neuropharmacology 44 (2003) 662-671
8. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275 (2000) 25965-25971
9. Engstrom M., Wurster S., Savola J.M., and Panula P. Functional properties of PFR(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors. Peptides 24 (2003) 1947-1954
10. Gouarderes C., Sutak M., Zajac J.M., and Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol 237 (1993) 73-81
11. 125I)EYF as selective radioligands. Neuroscience 115 (2002) 349-361
12. Gouarderes C., Faura C.C., and Zajac J.M. Rodent strain differences in the NPFF1 and NPFF2 receptor distribution and density in the central nervous system. Brain Res 1014 (2004) 61-70
13. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2 (2000) 703-708
14. Huang E.Y., Li J.Y., Tan P.P., Wong C.H., and Chen J.C. The cardiovascular effects of PFRFamide and PFR(Tic)amide, a possible agonist and antagonist of neuropeptide FF (NPFF). Peptides 21 (2000) 205-210
15. Huang E.Y., Li J.Y., Wong C.H., Tan P.P., and Chen J.C. Dansyl-PQRamide, a possible neuropeptide FF receptor antagonist, induces conditioned place preference. Peptides 23 (2002) 489-496
16. Li J.Y., Wong C.H., Huang E.Y., Lin Y.C., Chen Y.L., Tan P.P., et al. Modulations of spinal serotonin activity affect the development of morphine tolerance. Anesth Analg 92 (2001) 1563-1568
17. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., et al. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 276 (2001) 36961-36969
18. 2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11 (1990) 277-280
19. Marinissen M.J., and Gutkind J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol Sci 22 (2001) 368-376
20. Mollereau C., Mazarguil H., Marcus D., Quelven I., Kotani M., Lannoy V., et al. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol 451 (2002) 245-256
21. Oberling P., Stinus L., Le Moal M., and Simonnet G. Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides 14 (1993) 919-924
22. Panula P., Aarnisalo A.A., and Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog Neurobiol 48 (1996) 461-487
23. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1986), Academic Press, New York
24. Perry S.J., Huang E.Y., Cronk D., Bagust J., Sharma R.P., Walker R.J., et al. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 409 (1997) 426-430
25. Price D.A., and Greenberg M.J. Structure of a molluscan cardioexcitatory neuropeptide. Science 197 (1977) 670-671
26. Raffa R.B., Kim A., Rice K.C., de Costa B.R., Codd E.E., and Rothman R.B. Low affinity of FMRFamide and four FaRPs (FMRFamide-related peptides), including the mammalian-derived FaRPs F-8-Famide (NPFF) and A-18-Famide, for opioid mu, delta, kappa 1, kappa 2a, or kappa 2b receptors. Peptides 15 (1994) 401-404
27. Svenningsson P., Nishi A., Fisone G., Girault J.A., Nairn A.C., and Greengard P. DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44 (2004) 269-296
28. Tan P.P., Chen J.C., Li J.Y., Liang K.W., Wong C.H., and Huang E.Y. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs. Peptides 20 (1999) 1211-1217
29. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55 (1999) 804-811
30. Xu M., Kontinen V.K., Panula P., and Kalso E. Effects of (1DMe)NPYF, a synthetic neuropeptide FF analogue, in different pain models. Peptides 20 (1999) 1071-1077
31. Yang H.-Y.T., Fratta W., Majane E.A., and Costa E. Isolation sequencing, synthesis and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82 (1985) 7757-7761